Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging.
about
Non-invasive vulnerable plaque imaging: how do we know that treatment works?Non-coronary atherosclerosisIn vivo mapping of vascular inflammation using multimodal imagingPlaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events.Nanomedicine as a strategy to fight thrombotic diseases.Radial modulation contrast imaging using a 20-MHz single-element intravascular ultrasound catheter.Superficial femoral artery plaque, the ankle-brachial index, and leg symptoms in peripheral arterial disease: the walking and leg circulation study (WALCS) IIIPeripheral arterial disease assessment: wall, perfusion, and spectroscopyReproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonance.Plaque hemorrhage in carotid artery disease: pathogenesis, clinical and biomechanical considerations.Molecular imaging of inflammation in atherosclerosis.Quantification of plaque neovascularization using contrast ultrasound: a histologic validationMolecular imaging insights into early inflammatory stages of arterial and aortic valve calcification.Comparison between 2D and 3D high-resolution black-blood techniques for carotid artery wall imaging in clinically significant atherosclerosis.Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease.Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probeDiagnostic potential of differentially expressed Homer1, IL-1β, and TNF-α in coronary artery disease.The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population.Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.High-resolution intravascular magnetic resonance quantification of atherosclerotic plaque at 3T.Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in RatsMolecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinicSimultaneous morphological and biochemical endogenous optical imaging of atherosclerosisMultimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteriesAtherosclerosis: from biology to pharmacological treatment.Screening for atherosclerotic plaques in the abdominal aorta in high-risk patients with multicontrast-weighted MRI: a prospective study at 3.0 and 1.5 tesla.The 5-year projection on the future of interventional cardiology.Multidetector-row computed tomography for noninvasive coronary imaging.Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.Noninvasive cardiac imaging: implications for risk assessment in adolescents and young adults.The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.Correlation between Aortic Wall Thickness and Coronary Artery Disease by 64 Slice Multidetector Computed Tomography.Superficial femoral artery plaque and functional performance in peripheral arterial disease: walking and leg circulation study (WALCS III)MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.Imaging and molecular biomarkers of vulnerable atheromatous plaques.Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography.Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.Imaging subclinical atherosclerosis: is it ready for prime time? A review.Heterodimers of the transcriptional factors NFATc3 and FosB mediate tissue factor expression for 15(S)-hydroxyeicosatetraenoic acid-induced monocyte trafficking.
P2860
Q27020959-5FC680DD-708B-4E70-81A6-B616FFD6F83EQ27024872-BB555D92-2629-4898-B056-251CF8A160AAQ27318329-60CCA655-D0C0-4B6C-BE80-6BEF00EE8BCBQ30275428-4E0FEEF4-FE02-4E9B-A451-F06192CB3343Q30367197-1320CBE1-47FB-4875-8BB6-E9DF0717B682Q30411941-2BBFF270-9985-47C2-B0E0-C96A3A54CBC6Q30427051-C1EE65A1-A5D4-4DB6-8349-2761DA49F4F5Q30434383-16A4E778-C2F3-4C7A-9EA2-FC51D4D4D685Q30435014-73EEC5E6-3AF5-4F2C-BE8A-A04FB7C47F66Q30439717-D72CE439-F22A-41F5-ACCD-3747DC79AB27Q30446268-6DE4D071-20FA-4EC8-B528-6CEFAA78506CQ30469949-E53AD4F1-0B59-4C4B-954D-277A8D201404Q30474772-46CDEE0B-317C-4968-A99A-31997FAD499CQ33694318-CF7C450B-FD85-4B28-87C7-A16B8D74CEE7Q33719199-E65FEB2F-73AA-475E-BC3C-F211AF192853Q33839384-B7F197B5-C29B-4E4F-9D10-80C8A19FEBBBQ33868758-3E5E9CE2-A4E4-4C55-9689-9287AA37567CQ35016473-9B4788DF-BDB4-45D6-A4EF-B0B4DA260A74Q35190823-7CF1FBA8-7158-43F1-9751-C704476FB807Q35667247-B63870CF-38B5-4CE4-8463-2C127FF20382Q35922695-D7EA0B13-66AE-44AA-88A2-2D13902B054AQ36093873-FF4C67BB-42AF-47A4-B9FD-9B0AEE4B12CAQ36095916-87D8E8FD-925F-48F9-85D0-D4B0A592028DQ36117351-1F2CDE7E-B7B2-4BB4-8725-CEDA28522731Q36218239-FE73574E-FE1C-45AB-834B-3A50AC6E1B62Q36313684-A5CEA25E-72A2-45F9-9685-3E4AA20766F5Q36324958-F40074BC-7F14-4794-927D-B629E8C8495DQ36559145-6B411292-EFAA-402F-A348-E8E47C8F800BQ36569810-80EEA984-44BC-4A04-8E47-378005BA9554Q36580339-B3801AC4-1258-4937-8342-D5BA1156AC2BQ37280883-EBDD985D-0D4C-4E05-8C7F-46650956C283Q37296851-0BAB75A4-DCD7-4D2A-B532-07975BBF6622Q37301764-646B0003-B5B7-438E-94F1-EFC44B54C64EQ37531284-22B1DE58-0DFE-4D22-BD82-3010B4D7A268Q37664093-96FF9EA2-549D-42C3-81ED-F59736A255F6Q37755125-0236A92F-4300-42D2-8545-DE837D818471Q38067325-05FE6399-0E0C-4A9C-B595-D07D0ECE5B4BQ38094125-B071D73F-7007-405A-A10D-89FF47E897D7Q38239604-3ACE2DFF-4AA9-4C7D-8303-0BAEDD37742FQ38696812-B2813FFC-E34D-4292-8741-F43C3D266FAF
P2860
Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Atherothrombosis and high-risk ...... ic/magnetic resonance imaging.
@ast
Atherothrombosis and high-risk ...... ic/magnetic resonance imaging.
@en
type
label
Atherothrombosis and high-risk ...... ic/magnetic resonance imaging.
@ast
Atherothrombosis and high-risk ...... ic/magnetic resonance imaging.
@en
prefLabel
Atherothrombosis and high-risk ...... ic/magnetic resonance imaging.
@ast
Atherothrombosis and high-risk ...... ic/magnetic resonance imaging.
@en
P2093
P1476
Atherothrombosis and high-risk ...... ic/magnetic resonance imaging.
@en
P2093
Juan J Badimon
Michael Poon
Pedro R Moreno
Roberto Corti
Zahi A Fayad
P304
P356
10.1016/J.JACC.2005.03.075
P407
P577
2005-10-01T00:00:00Z